MRI Perfusion Scan Predicts Hip Damage in Babies After Treatment

When a baby is born with a dislocated hip, one of the most delicate moments in orthopedic medicine comes immediately after the surgeon gently nudges the joint back into place. The procedure, known as closed reduction, is often successful at restoring the anatomy of a hip affected by developmental dysplasia, one of the most common skeletal birth conditions. Yet a silent threat can follow the operation: the blood supply to the growing femoral head may be compromised during the repositioning, setting the stage for a devastating complication called avascular necrosis, in which the bone tissue of the hip literally begins to die from lack of oxygen. For decades, clinicians have had no reliable way to know, in the hours after surgery, whether a child’s hip is being quietly starved of blood. A new pilot study from China suggests that answer may now be available on the same day, using two advanced magnetic resonance imaging techniques that measure blood flow and water movement inside living bone.

The research, published in BMC Medical Imaging by a team of radiologists and orthopedic surgeons at Wuhan Children’s Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology, combined two complementary MRI methods: intravoxel incoherent motion imaging, or IVIM, and dynamic contrast-enhanced MRI, known as DCE-MRI. Both were performed within six hours after closed reduction on a group of sixteen young children, covering thirty-two hips in total. The goal was deceptively simple but technically ambitious: to extract quantitative numbers from the scans that could predict, before any symptom appears, which hips would go on to develop avascular necrosis over the following year and a half. In a field where treatment decisions are often made reactively, months after damage has already occurred, the prospect of an immediate, objective readout of hip perfusion represents a potentially significant shift in pediatric orthopedics.

To understand why this matters, it helps to grasp what each technique measures. IVIM is a diffusion-weighted MRI approach that does not require any contrast agent or injection. Instead, it exploits the fact that water molecules inside tissue move in two distinct ways: they diffuse randomly, as all molecules do, and they are also transported by the flow of blood through microscopic capillaries. By acquiring images at multiple different magnetic gradient strengths and fitting the signal decay mathematically, researchers can separate these two components. The fast component of the apparent diffusion coefficient, labeled ADC_fast in the study, reflects this microvascular perfusion, essentially providing a surrogate marker of how much blood is moving through the tiny vessels feeding the femoral head. When that value drops, it signals that capillary flow in the bone is diminished, exactly the physiological signature one would expect in the earliest phase of ischemic injury.

DCE-MRI takes a different route to the same physiological destination. In this technique, a gadolinium-based contrast agent is injected intravenously, and rapid serial images are captured as the agent sweeps through the tissue. By analyzing how quickly the contrast arrives, peaks, and washes out of the femoral head epiphysis, and by modeling this against the measured concentration in a feeding artery, a process that relies on what radiologists call the arterial input function, the method yields quantitative pharmacokinetic parameters. The most important of these for the current study was K_trans, the volume transfer constant, which describes the rate at which contrast moves from the blood plasma across the vessel wall into the surrounding tissue space. A low K_trans means that blood is either not reaching the tissue or not exchanging across the capillary bed, both hallmarks of compromised perfusion. Together, IVIM and DCE-MRI interrogate the same microcirculation from two independent physical angles, one through the motion of water and one through the transit of a tracer.

The clinical stakes are high because avascular necrosis after hip reduction is both common and consequential. In this pilot cohort, twelve of the thirty-two hips, or 37.5 percent, went on to develop the complication during follow-up, a figure consistent with the substantial risk that has long been recognized in this patient population. The condition is graded using the Bucholz-Ogden classification, a radiographic system applied here at six, twelve, and eighteen months after surgery. Once avascular necrosis takes hold, the femoral head can deform, the joint can become incongruous, and the child may face a lifetime of pain, limited mobility, and repeated corrective procedures. Detecting the ischemic process on the day of reduction, rather than months later when structural changes become visible on plain radiographs, would give clinicians a window in which protective strategies, altered immobilization, closer surveillance, or modified rehabilitation, might still alter the trajectory.

The study’s methodology reflects careful attention to the reproducibility problems that have historically plagued quantitative imaging. Two independent readers measured all IVIM and DCE-MRI parameters in the femoral head epiphyses, and their agreement was assessed using intraclass correlation coefficients. The results were striking: every parameter showed excellent inter-reader reproducibility, with ICC values ranging from 0.817 to 0.996. In practical terms, this means the measurements are not dependent on which radiologist happens to draw the region of interest, a crucial prerequisite for any biomarker hoping to move from the research lab into routine clinical use. Quantitative imaging has often stumbled at exactly this hurdle, with parameters that look promising in one reader’s hands but collapse under scrutiny from another, so the near-perfect agreement reported here is a meaningful technical achievement in its own right.

When the researchers compared the hips that developed avascular necrosis with those that did not, a clear physiological pattern emerged. The affected hips showed significantly lower values of both ADC_fast from IVIM and K_trans from DCE-MRI, confirming that reduced microvascular perfusion in the immediate post-reduction period precedes and predicts the eventual radiographic appearance of bone death. The team then built a predictive model combining the two parameters. Because the sample was small, they used Firth’s penalized logistic regression, a statistical method specifically designed to produce stable estimates when the number of events is limited and conventional logistic regression would be prone to bias. The combined ADC_fast plus K_trans model achieved an apparent area under the receiver operating characteristic curve, or AUC, of 0.963, with a 95 percent confidence interval stretching from 0.904 to 1.000. In clinical terms, the model identified every single hip that developed avascular necrosis, yielding 100 percent sensitivity, while correctly clearing 90 percent of the healthy hips.

Impressive as those numbers are, the authors were appropriately cautious about overfitting, the perennial danger of small imaging studies where a model can memorize the quirks of its own dataset rather than learning a generalizable pattern. To address this, they applied bootstrap internal validation, a resampling technique that repeatedly refits the model on random subsets and tests it on the held-out remainder, providing a corrected estimate of real-world performance. The bootstrap-corrected AUC came in at 0.952, barely below the apparent value, which suggests the model’s discriminative power is robust rather than an artifact of the small sample. Even so, the researchers themselves emphasize that this remains a pilot study, and they explicitly call for prospective multicenter validation before the technique can be recommended for clinical implementation. Sixteen children is a foundation, not a finished edifice, and the history of predictive biomarkers is littered with promising pilots that failed to replicate at scale.

Nevertheless, the conceptual advance is considerable. The study was conducted under ethical approval from the Medical Ethics Committee of Wuhan Children’s Hospital, with written informed consent from the guardians of all participants, and it was supported by the Construction Project of the Wuhan Clinical Research Center for Children’s Medical Imaging. Its open-access publication means that other pediatric imaging centers can scrutinize the methods and attempt replication immediately. If larger, multi-institutional studies confirm the findings, the practical implications could be transformative: a child undergoing closed reduction would receive a combined IVIM and DCE-MRI scan within hours of surgery, and the quantitative perfusion signature would stratify risk on day one. High-risk hips could be flagged for intensified follow-up and potentially protective interventions, while low-risk families could be spared years of anxious surveillance. The femoral head, once a black box whose fate revealed itself only over months of radiographs, would become a transparent, quantitatively monitored organ from the very first hours of treatment.

There is also a broader lesson here for the field of quantitative MRI. IVIM and DCE-MRI are mature techniques in adult oncology and neuroimaging, but applying them to the tiny, rapidly developing femoral heads of infants, inside a cast, within six hours of surgery, and on a 3 Tesla scanner, demanded substantial technical adaptation. The excellent reproducibility figures reported by the Wuhan team suggest that such adaptation is feasible and that quantitative perfusion imaging can be pushed into some of the most challenging corners of pediatric medicine. As the authors note, the work is an early step, but it points toward a future in which the earliest, most treatable phase of avascular necrosis is no longer invisible, and in which the decision to watch, wait, or intervene is guided not by guesswork but by numbers measured directly from the child’s own blood supply.

Subject of Research: Early MRI-based prediction of avascular necrosis after closed reduction for developmental dysplasia of the hip

Article Title: Combined IVIM and DCE-MRI for early prediction of avascular necrosis after closed reduction in developmental dysplasia of the hip: a pilot study

Article References: Guo, Y., Peng, X., Wu, X., Zhu, B., Li, J., Xia, W., Shen, X., & Shao, J. (2026). Combined IVIM and DCE-MRI for early prediction of avascular necrosis after closed reduction in developmental dysplasia of the hip: a pilot study. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02936-6

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02936-6

Keywords: avascular necrosis, developmental dysplasia of the hip, IVIM, DCE-MRI, pediatric orthopedics, magnetic resonance imaging, quantitative imaging biomarkers, closed reduction, femoral head perfusion, ADC_fast, K_trans, predictive modeling